Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients

BACKGROUND: Interleukin-2 (IL-2) treatment for patients with metastatic melanoma has shown remarkable durable responses. Systemic administration of IL-2 may cause severe side effects, whereas local administration is considered to be a safe alternative. The lungs are common sites of metastases in mel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Posch, C, Weihsengruber, F, Bartsch, K, Feichtenschlager, V, Sanlorenzo, M, Vujic, I, Monshi, B, Ortiz-Urda, S, Rappersberger, K
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3960625/
https://ncbi.nlm.nih.gov/pubmed/24518593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares